Anzeige
Mehr »
Login
Donnerstag, 05.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 08.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
08.02.Babcock International Group - Steadfast defence496Babcock's capital markets day reaffirmed its transformation over the past two years, facilitated by a series of disposals and a focus on core defence expertise (69% of H124 revenue). It is well positioned...
► Artikel lesen
08.02.Creo Medical - Solid FY23 lays the groundwork for 2024321Creo Medical has released a trading update for FY23, an active year for the company, with progress made across all business segments. Traction improved in H223, following Speedboat Inject's European...
► Artikel lesen
08.02.Nanoco - Steps on the pathway to volume production280Nanoco's trading update confirms that H124 revenues and EBITDA are anticipated to be in line with company expectations. The main new information is that the company has commenced the build and fitout...
► Artikel lesen
08.02.Intralot Integrated Lottery Systems and Services - In it to win it337Intralot Integrated Lottery Systems and Services (Intralot) is a leading developer and supplier of integrated gaming systems and services that cover the entire value chain of select gaming markets....
► Artikel lesen
08.02.AFT Pharmaceuticals - US maiden voyage with Maxigesic IV launch266AFT Pharmaceuticals has announced the launch of Maxigesic IV, an intravenous form of its flagship pain relief prescription medicine, in the US market by licensing partner Hikma, under the brand name...
► Artikel lesen
08.02.VolitionRx - Snaring sepsis, with early NETs detection499VolitionRx continues to make headway in growing a body of clinical evidence to build Nu.Q® NETs as a potential breakthrough tool in sepsis. These efforts, coupled with its CE mark in Europe, are a strong...
► Artikel lesen